| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 3-Feb-07 | | Total Revenue | 9,043,000 | 10,134,000 | 10,671,000 | | Cost of Revenue | 6,037,000 | 6,592,000 | 6,658,000 | | | Gross Profit | 3,006,000 | 3,542,000 | 4,013,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,311,000 | 2,662,000 | 2,837,000 | | Non Recurring | 215,000 | (230,000) |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 480,000 | 1,110,000 | 1,176,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 41,000 | 146,000 | 23,000 | | Earnings Before Interest And Taxes | 634,000 | 1,278,000 | 1,199,000 | | Interest Expense | 181,000 | 149,000 | 102,000 | | Income Before Tax | 453,000 | 1,129,000 | 1,097,000 | | Income Tax Expense | 233,000 | 411,000 | 422,000 | | Minority Interest | 4,000 | 22,000 |
-
| | | | Net Income From Continuing Ops | 220,000 | 718,000 | 675,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 1,000 | | Other Items |
-
|
-
|
-
| | | | Net Income | 220,000 | 718,000 | 676,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $220,000 | $718,000 | $676,000 |
|
1.48% Nasdaq 
Income Statement
